Elimination of CD4+ T Cells Enhances Anti-Tumor Effect of Locally Secreted Interleukin-12 on B16 Mouse Melanoma and Induces Vitiligo-Like Coat Color Alteration
Authors:
- Hiroshi NagaiHNHiroshi Nagai
- Tatsuya HorikawaTHTatsuya Horikawa
- Masahiro OkaMOMasahiro Oka
- Masamitsu IchihashiMIMasamitsu Ichihashi
- Isao HaraIHIsao Hara
- Sadao KamidonoSKSadao Kamidono
- 1 December 2000
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 115 (6) , 1059-1064
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Autoantibodies to tyrosinase‐related protein‐1 detected in the sera of vitiligo patients using a quantitative radiobinding assayBritish Journal of Dermatology, 1998
- The expanding universe of T-cell subsets: Th1, Th2 and moreImmunology Today, 1996
- T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.Journal of Experimental Medicine, 1996
- Immunoregulatory effects of CD4+ T helper subsets in human melanomaSurgery, 1995
- CD4 T cells inhibit in vivo the CD8‐mediated immune response against murine colon carcinoma cells transduced with interleukin‐12 genesEuropean Journal of Immunology, 1995
- Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivoEuropean Journal of Immunology, 1993
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.Journal of Experimental Medicine, 1984
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983
- Mechanisms of T Cell-B Cell InteractionAnnual Review of Immunology, 1983